For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival.
EGF considerably increases skin cell regeneration. More precisely, they can directly communicate to the skin cells to produce more collagen and elastin, that's why most skin care maker use EGF to care our skin.
And we only investigate the epidermal growth factor (EGF) cosmetic, take no account of the epidermal growth factor (EGF) for research use.
Scope of the Report:
The classification of Epidermal Growth Factor (EGF) includes liquid and powder. The proportion of liquid in 2016 is about 25%, the proportion of powder in 2016 is about 75%.
The application of Epidermal Growth Factor (EGF) is divided into EGF Cream, EGF Lotion, EGF Mask and others. The most of Epidermal Growth Factor (EGF) is EGF Cream, and the market share of that is about 45% in 2016.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 34% in 2016. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 25% in 2016. And South America in the third largest consumption region with the consumption market share of 10%.
Market competition is intense. Pavay, Radiant, BIO-FD&C, LipoTrue, BIOEFFECT are the leaders of the industry, with high-end customers in the industry.
The worldwide market for Epidermal Growth Factor (EGF) (CAS 62253-63-8) is expected to grow at a CAGR of roughly 5.8% over the next five years, will reach 140 million US$ in 2024, from 110 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Epidermal Growth Factor (EGF) (CAS 62253-63-8) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- EGF Cream
- EGF Lotion
- EGF Mask
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Epidermal Growth Factor (EGF) (CAS 62253-63-8) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Epidermal Growth Factor (EGF) (CAS 62253-63-8), with price, sales, revenue and global market share of Epidermal Growth Factor (EGF) (CAS 62253-63-8) in 2017 and 2018.
Chapter 3, the Epidermal Growth Factor (EGF) (CAS 62253-63-8) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Epidermal Growth Factor (EGF) (CAS 62253-63-8) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Epidermal Growth Factor (EGF) (CAS 62253-63-8) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Epidermal Growth Factor (EGF) (CAS 62253-63-8) sales channel, distributors, customers, research findings and conclusion, appendix and data source.